Prevalence and mechanism of nonsteroidal anti-inflammatory drug-induced clinical relapse in patients with inflammatory bowel disease.

[1]  G. Bonner,et al.  A Long-term Cohort Study of Nonsteroidal Anti-inflammatory Drug Use and Disease Activity in Outpatients with Inflammatory Bowel Disease , 2004, Inflammatory bowel diseases.

[2]  S. Targan,et al.  The Spectrum of Gastrointestinal Toxicity and Effect on Disease Activity of Selective Cyclooxygenase-2 Inhibitors in Patients with Inflammatory Bowel Disease , 2004, Inflammatory bowel diseases.

[3]  R. Langenbach,et al.  The effects of aspirin on gastric mucosal integrity, surface hydrophobicity, and prostaglandin metabolism in cyclooxygenase knockout mice. , 2004, Gastroenterology.

[4]  C. Hawkey,et al.  Reduced incidence of gastroduodenal ulcers associated with lumiracoxib compared with ibuprofen in patients with rheumatoid arthritis , 2004, Alimentary pharmacology & therapeutics.

[5]  C. Patrono,et al.  Clinical Pharmacology of Platelet, Monocyte, and Vascular Cyclooxygenase Inhibition by Naproxen and Low-Dose Aspirin in Healthy Subjects , 2004, Circulation.

[6]  I. Bjarnason,et al.  The G.U.T. of gut , 2004, Scandinavian journal of gastroenterology.

[7]  J. Wallace,et al.  Interaction of a selective cyclooxygenase-2 inhibitor with aspirin and NO-releasing aspirin in the human gastric mucosa , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[8]  R. Botting.  COX-1 and COX-3 inhibitors. , 2003, Thrombosis research.

[9]  R. Modigliani,et al.  Exacerbation of Crohn's colitis with severe colonic hemorrhage in a patient on rofecoxib. , 2002 .

[10]  I. Forgacs,et al.  Use of surrogate markers of inflammation and Rome criteria to distinguish organic from nonorganic intestinal disease. , 2002, Gastroenterology.

[11]  W. Sandborn,et al.  Safety of selective cyclooxygenase-2 inhibitors in inflammatory bowel disease. , 2002 .

[12]  I. Bjarnason,et al.  Inflammatory bowel disease and spondylarthropathy. , 2001, Arthritis and rheumatism.

[13]  G. Bonner.  Exacerbation of inflammatory bowel disease associated with use of celecoxib. , 2001 .

[14]  O. Kronborg,et al.  A new fecal calprotectin test for colorectal neoplasia. Clinical results and comparison with previous method. , 2001, Scandinavian journal of gastroenterology.

[15]  B. Thjódleifsson,et al.  Selective inhibition of COX-2 in humans is associated with less gastrointestinal injury: a comparison of nimesulide and naproxen , 2001, Gut.

[16]  B. Thjódleifsson,et al.  A simple method for assessing intestinal inflammation in Crohn's disease , 2000, Gut.

[17]  J. Wallace,et al.  NSAID-induced gastric damage in rats: requirement for inhibition of both cyclooxygenase 1 and 2. , 2000, Gastroenterology.

[18]  L. Kitchen,et al.  Tolerance of nonsteroidal antiinflammatory drugs in patients with inflammatory bowel disease , 2000, American Journal of Gastroenterology.

[19]  B. Korelitz,et al.  Effects of nonsteroidal antiinflammatory drugs on inflammatory bowel disease: a case-control study , 2000, American Journal of Gastroenterology.

[20]  I. Bjarnason,et al.  Surrogate markers of intestinal inflammation are predictive of relapse in patients with inflammatory bowel disease. , 2000, Gastroenterology.

[21]  A. Püspök,et al.  Clinical, endoscopic, and histologic spectrum of nonsteroidal anti-inflammatory drug-induced lesions in the colon , 2000, Diseases of the colon and rectum.

[22]  R. Lorenz,et al.  Cyclooxygenase-2-dependent arachidonic acid metabolites are essential modulators of the intestinal immune response to dietary antigen , 1999, Nature Medicine.

[23]  J. Vane,et al.  Nonsteroid drug selectivities for cyclo-oxygenase-1 rather than cyclo-oxygenase-2 are associated with human gastrointestinal toxicity: a full in vitro analysis. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[24]  M. Wolfe,et al.  Gastrointestinal toxicity of nonsteroidal antiinflammatory drugs. , 1999, The New England journal of medicine.

[25]  J. Evans,et al.  Non-steroidal anti-inflammatory drugs are associated with emergency admission to hospital for colitis due to inflammatory bowel disease. , 1997, Gut.

[26]  J. Wrigglesworth,et al.  Nonsteroidal antiinflammatory drugs and uncoupling of mitochondrial oxidative phosphorylation. , 1996, Arthritis and rheumatism.

[27]  D. Kelleher,et al.  Microalbuminuria correlates with intestinal histopathological grading in patients with inflammatory bowel disease. , 1996, Gut.

[28]  A. Macpherson,et al.  Side effects of nonsteroidal anti-inflammatory drugs on the small and large intestine in humans. , 1993, Gastroenterology.

[29]  A. Røseth,et al.  Assessment of the neutrophil dominating protein calprotectin in feces. A methodologic study. , 1992, Scandinavian journal of gastroenterology.

[30]  H. Kaufmann,et al.  Nonsteroidal anti-inflammatory drugs activate quiescent inflammatory bowel disease. , 1987, Annals of internal medicine.

[31]  A. Levi,et al.  Effect of non-steroidal anti-inflammatory drugs and prostaglandins on the permeability of the human small intestine. , 1986, Gut.

[32]  K. Ewe,et al.  European cooperative Crohn's disease study (ECCDS) : Results of drug treatment , 1984 .

[33]  D. Rampton,et al.  Analgesic ingestion and other factors preceding relapse in ulcerative colitis. , 1983, Gut.

[34]  D. Rampton,et al.  Relapse of ulcerative proctocolitis during treatment with non-steroidal anti-inflammatory drugs. , 1981, Postgraduate medical journal.

[35]  D. Rampton,et al.  Prostaglandin synthesis inhibitors in ulcerative colitis: flurbiprofen compared with conventional treatment. , 1981, Prostaglandins.

[36]  R. F. Harvey,et al.  A SIMPLE INDEX OF CROHN'S-DISEASE ACTIVITY , 1980, The Lancet.

[37]  A. Thomson.  NSAID-Induced Gastric Damage in Rats , 2001 .

[38]  A. Røseth,et al.  Correlation between faecal excretion of indium-111-labelled granulocytes and calprotectin, a granulocyte marker protein, in patients with inflammatory bowel disease. , 1999, Scandinavian journal of gastroenterology.

[39]  R. Simpson,et al.  Comparison of indomethacin and nimesulide, a selective cyclooxygenase-2 inhibitor, on key pathophysiologic steps in the pathogenesis of nonsteroidal anti-inflammatory drug enteropathy in the rat. , 1998, Scandinavian journal of gastroenterology.

[40]  J. Vane,et al.  Aspirin and Other Salicylates , 1993 .

[41]  G. Labó,et al.  Prostaglandins, indomethacin, and ulcerative colitis , 1980 .